CORC

浏览/检索结果: 共7条,第1-7条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Safety and Efficacy of Sofosbuvir/Velpatasvir in Genotype 1-6 HCV-Infected Patients in China: Results from a Phase 3 Clinical Trial 会议论文
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, NOV 09-13, 2018
作者:  Wei, Lai;  Xie, Qing;  Huang, Yan;  Wu, Shanming;  Xu, Min
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/31
Increased and sustained HBsAg loss in HBeAg positive CHB patients switched from NUC to Peg-IFN alfa-2a: A randomised open label trial (NEW SWITCH study) 会议论文
作者:  Hu, Peng;  Dou, Xiaoguang;  Jiang, Jian-ning;  Jia, Shang;  Zhang, Wen Hong
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/06
A multi-center randomized study on the efficacy and safety of switching to peginterferon alpha-2a (40KD) for 48 or 96 weeks in HBeAg positive CHB patients with a prior NUC history for 1 to 3 years: an interim analysis of NEW SWITCH study 会议论文
作者:  Hu, Peng;  Jia, Shang;  Zhang, Wen Hong;  Gong, Guozhong;  Li, Yongguo
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 会议论文
作者:  Cheng, Jun;  Yu, Yanyan;  Wang, Hao;  Xu, Min;  Shi, Guangfeng
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Baseline Quantitative Hepatitis B Core antibody is the Strongest Predictor for 2-year HBeAg seroconversion in HBeAg Positive CHB Patients Treated with Telbivudine Alone or Combined with Adefovir 会议论文
作者:  Sun, Jian;  Yuan, Quan;  Xie, Qing;  Fan, Rong;  Tan, Deming
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
PREVALENCE OF HCV AND HOST IL28B GENOTYPES IN CHINA 会议论文
作者:  Wei, Lai;  Lopez-Talavera, Juan Carlos;  Rao, Huiying;  Jia, Shang;  Sun, Yongtao
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
PREVALENCE OF HCV AND HOST IL28B GENOTYPES IN CHINA 会议论文
作者:  Wei, Lai;  Lopez-Talavera, Juan Carlos;  Rao, Huiying;  Jia, Shang;  Sun, Yongtao
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace